SIEGALL CLAY B 4
4 · Immunome Inc. · Filed Jul 31, 2025
Insider Transaction Report
Form 4
Immunome Inc.IMNM
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2025-07-29+800,000→ 800,000 totalExercise: $10.60Exp: 2035-07-28→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.